Group 1 - The signing ceremony for the "Clinical Research Project Cooperation between Jinan University and Zhongjing Wanshi Pharmaceutical" was successfully held, focusing on the integration of traditional Chinese medicine and modern medical research [3][5] - The project aims to explore the essence and regulatory mechanisms of "kidney deficiency syndrome" in elderly degenerative diseases, responding to the increasing prevalence of conditions such as osteoporosis, knee osteoarthritis, and Alzheimer's disease in an aging population [7][9] - Zhongjing Wanshi Pharmaceutical emphasizes the importance of high-quality medicinal materials and aims to innovate and modernize traditional Chinese medicine through this collaboration, which is seen as a significant step towards the internationalization of Chinese medicine [9] Group 2 - The expert team conducted multi-dimensional discussions on research proposals for kidney deficiency syndrome related to elderly osteoporosis, knee osteoarthritis, and Alzheimer's disease, under the leadership of key professors [9]

Core Viewpoint - The collaboration between Jinan University and Zhongjing Wanshi Pharmaceutical aims to conduct clinical research on age-related degenerative diseases, leveraging traditional Chinese medicine (TCM) to address conditions such as osteoporosis, knee osteoarthritis, and Alzheimer's disease, particularly focusing on the concept of kidney deficiency [4][6]. Group 1: Event Overview - The signing ceremony for the clinical research project was held on April 29, organized by Jinan University and attended by various experts and scholars from Guangdong [2]. - Key representatives included Zhang Ronghua, Vice President of Jinan University, and Ma Yun, Deputy General Manager of Zhongjing Wanshi Pharmaceutical, who signed the cooperation agreement [6]. Group 2: Research Focus - The project will explore the pathological mechanisms and key targets of age-related degenerative diseases, emphasizing the role of kidney deficiency in these conditions [6]. - The research aims to innovate TCM applications, particularly the modern use of classic formulas like Zuo Gui Wan and You Gui Wan, in treating kidney deficiency-related diseases [4][6]. Group 3: Collaborative Goals - The collaboration seeks to integrate multidisciplinary approaches to enhance the understanding and treatment of age-related diseases through TCM [6]. - Zhongjing Wanshi Pharmaceutical emphasizes the importance of high-quality medicinal materials and aims to explore new treatment pathways that combine TCM and Western medicine [6].